Deutsche Bank Ag\ Adma Biologics, Inc. Transaction History

Deutsche Bank Ag\

$262 Billion
Q2 2025

A detailed history of Deutsche Bank Ag\ transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,871,228 shares of ADMA stock, worth $31.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,871,228

Previous 3,363,639 44.37%

Holding current value

$31.4 Million

Previous $66.7 Million 48.94%

% of portfolio

0.01%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$17.6 - $24.51 $26.3 Million - $36.6 Million	-1,492,411 Reduced 44.37%	1,871,228 $34.1 Million
Q1 2025 May 09, 2025	SELL	$15.44 - $20.61 $7.91 Million - $10.6 Million	-512,069 Reduced 13.21%	3,363,639 $66.7 Million
Q4 2024 Jun 30, 2025	BUY	$15.62 - $22.62 $8 Million - $11.6 Million	512,069 Added 15.22%	3,875,708 $66.5 Million
Q4 2024 Feb 14, 2025	SELL	$15.62 - $22.62 $4 Million - $5.8 Million	-256,311 Reduced 6.2%	3,875,708 $66.5 Million
Q3 2024 Jun 26, 2025	BUY	$11.21 - $20.03 $8.61 Million - $15.4 Million	768,380 Added 22.84%	4,132,019 $82.6 Million
Q3 2024 Nov 13, 2024	BUY	$11.21 - $20.03 $12.2 Million - $21.8 Million	1,087,844 Added 35.74%	4,132,019 $82.6 Million
Q2 2024 Jun 12, 2025	SELL	$5.98 - $11.18 $1.91 Million - $3.57 Million	-319,464 Reduced 9.5%	3,044,175 $34 Million
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $49,448 - $92,447	-8,269 Reduced 0.27%	3,044,175 $34 Million
Q1 2024 Jun 02, 2025	SELL	$4.4 - $6.74 $1.37 Million - $2.1 Million	-311,195 Reduced 9.25%	3,052,444 $20.1 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $12,636 - $19,357	-2,872 Reduced 0.09%	3,052,444 $20.1 Million
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $9.08 Million - $13.3 Million	2,947,382 Added 2730.73%	3,055,316 $13.8 Million
Q3 2023 Nov 09, 2023	BUY	$3.47 - $4.61 $85,695 - $113,848	24,696 Added 29.67%	107,934 $386,000
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $151,064 - $204,323	-48,418 Reduced 36.78%	83,238 $307,000
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $122,190 - $157,102	-40,595 Reduced 23.57%	131,656 $435,000
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $22,007 - $34,570	8,910 Added 5.45%	172,251 $668,000
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $25,210 - $35,518	-12,419 Reduced 7.07%	163,341 $397,000
Q2 2022 Aug 11, 2022	BUY	$1.43 - $2.2 $129,214 - $198,792	90,360 Added 105.81%	175,760 $348,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.07 $66,204 - $90,757	-43,844 Reduced 33.92%	85,400 $137,000
Q1 2021 May 13, 2021	SELL	$1.67 - $2.95 $2,085 - $3,684	-1,249 Reduced 0.96%	129,244 $227,000
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $86,481 - $122,995	-48,045 Reduced 26.91%	130,493 $255,000
Q3 2020 Nov 12, 2020	SELL	$2.04 - $3.74 $458,267 - $840,157	-224,641 Reduced 55.72%	178,538 $427,000
Q2 2020 Aug 13, 2020	BUY	$2.42 - $3.29 $709,534 - $964,614	293,196 Added 266.58%	403,179 $1.18 Million
Q1 2020 May 14, 2020	BUY	$1.5 - $4.59 $8,238 - $25,208	5,492 Added 5.26%	109,983 $317,000
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $13,385 - $17,721	3,441 Added 3.41%	104,491 $417,000
Q3 2019 Nov 14, 2019	BUY	$3.19 - $5.39 $206,964 - $349,697	64,879 Added 179.37%	101,050 $448,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $41,835 - $62,277	11,885 Added 48.94%	36,171 $139,000
Q1 2019 May 15, 2019	SELL	$2.61 - $4.35 $2,205 - $3,675	-845 Reduced 3.36%	24,286 $91,000
Q4 2018 Feb 14, 2019	SELL	$2.17 - $6.12 $186,355 - $525,573	-85,878 Reduced 77.36%	25,131 $59,000
Q3 2018 Dec 21, 2021	BUY	$4.39 - $6.85 $22,371 - $34,907	5,096 Added 4.81%	111,009 $689,000
Q3 2018 Nov 14, 2018	BUY	$4.39 - $6.85 $305,609 - $476,862	69,615 Added 191.79%	105,913 $657,000
Q2 2018 Apr 21, 2020	BUY	$4.39 - $5.44 $26,950 - $33,396	6,139 Added 20.36%	36,298 $163,000
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $132,398 - $164,064	30,159 New	30,159 $135,000

Others Institutions Holding ADMA

# of Institutions

407

Shares Held

193M

Call Options Held

2.13M

Put Options Held

1.59M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.29B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account